Cdk5 exists in brain extracts in multiple forms, one of which is a mac
romolecular protein complex comprising Cdk5, neuron-specific Cdk5 acti
vator p35(nck5a) and other protein components (Lee, K.-Y., Resales, J.
L., Tang, D., and Wang, J. H. (1996) J. Biol. Chem. 271, 1538-1543).
The yeast two-hybrid system was employed to identify p35(nck5a)-intera
cting proteins from a human brain cDNA library. One of the isolated cl
ones encodes a fragment of glial fibrillary acidic protein, which is a
glial-specific protein. Sequence alignment revealed significant homol
ogy between the p35(nck5a)-binding fragment of glial fibrillary acidic
protein and corresponding regions in neurofilaments. The association
between p35(nck5a) and neurofilament medium molecular weight subunit (
NF-M) was confirmed by both the yeast two-hybrid assay and direct bind
ing of the bacteria-expressed proteins. The p35(nck5a) binding site on
NF-M was mapped to a carboxyl-terminal region of the rod domain, in c
lose proximity to the putative Cdk5 phosphorylation sites in NF-M, A r
egion immediately amino-terminal to the kinase-activating domain in p3
5(nck5a) is required for its binding with NF-M. In in vitro binding as
says, NF-M binds both monomeric p35(nck5a) and the Cdk5/p35(nck5a) com
plex. The binding of NF-M has no effect on the kinase activity of Cdk5
/p35(nck5a).